Keratitis Clinical Trial
Official title:
Efficacy of Mutilayered Fresh Amnoitic Membrane Transplantation in Resistant Fungal Keratitis
Corneal infection or infectious keratitis (IK) is the most common cause of corneal blindness worldwide, particu-larly in the developing countries1. The incidence was estimated at 2.5-799 per 100,000 population/year. It is a painful and potentially blinding ocular emergency that often requires hospital admission for intensive medical and/or surgical treatment. Depending on the geographical and temporal variations and population-based risk factors (e.g. agricultural practice, trauma, use of contact lens and others), bacteria and fungi have been shown to be the main causative microorganisms for IK, followed by viruses, parasites and polymicrobial infection. Amniotic membrane (AM) is the innermost layer of the placenta, which consists of a single layer of meta-bolically active epithelium, a thick basement membrane, and an avascular stromal matrix (15). It has been shown to exhibit a wide array of biological properties, including wound healing, anti-inflammatory, antimicrobial, and anti-angiogenic properties, amongst others. To date, a number of studies have evaluated the benefit of AMT for treating active IK, though the majority of them were of small case series or case reports. In clinical practice, AMT is usually reserved as a second-line therapy in IK, mainly to promote cornea healing in non-healing ulcer after the sterilization phase.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00513734 -
A Comparison of Hydrogel Dressings and Ocular Lubricants in the Prevention on Corneal Damage in the Critically Ill
|
N/A | |
| Enrolling by invitation |
NCT03436576 -
Efficacy of Two Concentrations of Autologous Serum for the Treatment of Severe Dry Eye
|
Phase 3 | |
| Recruiting |
NCT06229379 -
The Effects of a Large Language Model on Clinical Questioning Skills
|
N/A | |
| Completed |
NCT01268306 -
Study of the Presence and Extent of Corneal Disturbance Associated With B+L Biotrue MPS Used With B+L PureVision Lenses
|
Phase 4 | |
| Completed |
NCT01028027 -
Loteprednol and Tobramycin Versus Tobramycin and Dexamethasone, in the Treatment of Blepharokeratoconjunctivitis
|
Phase 3 | |
| Recruiting |
NCT05432336 -
Complex Ocular Infection, Optimization of Microbiological Diagnosis
|
||
| Completed |
NCT04169061 -
Impact of Acthar on Everyday Life of Participants With Severe Keratitis
|
Phase 4 | |
| Completed |
NCT03237936 -
Effect of IKERVIS® Eye Drops Once Daily on the Quality of Vision in Dry Eye Disease Patients With Severe Keratitis
|
Phase 4 | |
| Completed |
NCT00001734 -
Screening for NEI Clinical Studies
|
N/A | |
| Recruiting |
NCT05255107 -
Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Previously Untreated Corneal Ulcers
|
Phase 2/Phase 3 | |
| Recruiting |
NCT05255016 -
Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Refractory Corneal Ulcers
|
Phase 2/Phase 3 | |
| Terminated |
NCT05250583 -
Use of a Biological Lens of Amniotic Membrane (LV-Visio-AMTRIX) in the Treatment of Treatment-Resistant Keratitis
|
Phase 2 | |
| Recruiting |
NCT02865876 -
Effectiveness of Corneal Accelerated Crosslinking for Infectious Keratitis
|
Phase 3 | |
| Terminated |
NCT02116062 -
Robotic Surgery of the Ocular Surface
|
N/A | |
| Recruiting |
NCT00838422 -
Reliability of Pachymetry Measurement With FD-oCT, ORA, Confoscan 4 and Ultrasound
|
N/A | |
| Completed |
NCT00949468 -
Microbiological Keratitis in a Countryside City of Brazil
|
N/A | |
| Completed |
NCT03586505 -
Tolerance to Light for Patients Suffering From Keratitis
|
N/A | |
| Recruiting |
NCT04420962 -
Automated Quantitative Ulcer Analysis Study
|
||
| Completed |
NCT02186431 -
Contact Lenses and Infiltrative Keratitis
|
N/A | |
| Completed |
NCT05538793 -
Deep Learning for the Discrimination Among Different Types of Keratits: a Nationwide Study
|